Cristina Mecucci

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications

Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia.

Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia.

Journal: Annals of hematology
Published: March 10, 2026

DDX10 RNA Helicase: Structure, Function, and Oncogenic Roles Across Solid and Hematologic Tumors.

DDX10 RNA Helicase: Structure, Function, and Oncogenic Roles Across Solid and Hematologic Tumors.

Journal: Genes
Published: December 18, 2025

A new c.681dup RUNX1 variant in familial leukemia.

A new c.681dup RUNX1 variant in familial leukemia.

Journal: Familial cancer
Published: October 09, 2025

Lipidomic and metabolomic analysis of human erythrocytes during storage for transfusion applications.

Lipidomic and metabolomic analysis of human erythrocytes during storage for transfusion applications.

Journal: Blood transfusion = Trasfusione del sangue
Published: August 31, 2025

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Journal: Blood
Published: August 29, 2025

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Journal: Blood
Published: August 29, 2025

CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT.

CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT.

Journal: Blood advances
Published: August 06, 2025

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Journal: Blood
Published: June 27, 2025

The c.2031-2A>C MPO gene variant and the predisposition to myeloid neoplasms.

The c.2031-2A>C MPO gene variant and the predisposition to myeloid neoplasms.

Journal: Annals of hematology
Published: May 14, 2025

Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports.

Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports.

Journal: Annals of hematology
Published: May 11, 2025

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.

A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.

Journal: Blood
Published: April 09, 2025

Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia.

Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia.

Journal: Blood
Published: February 25, 2025
Showing 1-12 of 129

Last Updated: 09/26/2026